These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 39292326)

  • 21. Comprehensive immunohistochemical analysis of N6-methyladenosine (m6A) writers, erasers, and readers in endometrial cancer.
    Ralser DJ; Condic M; Klümper N; Ellinger J; Staerk C; Egger EK; Kristiansen G; Mustea A; Thiesler T
    J Cancer Res Clin Oncol; 2023 Jun; 149(6):2417-2424. PubMed ID: 35731272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expressions of m6A RNA methylation regulators and their clinical predictive value in cervical squamous cell carcinoma and endometrial adenocarcinoma.
    Wu H; Dong H; Fu Y; Tang Y; Dai M; Chen Y; Wang G; Wu Y
    Clin Exp Pharmacol Physiol; 2021 Feb; 48(2):270-278. PubMed ID: 33006785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of n6-methyladenosine (m6A) regulators and role of FTO/TNC in scleroderma.
    Yu Y; Liang C; Tang Q; Shi Y; Shen L
    Gene; 2024 Feb; 894():147989. PubMed ID: 37972699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and validation of a m
    Zhao X; Cui L
    Am J Cancer Res; 2019; 9(10):2156-2169. PubMed ID: 31720080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction and validation of m6A-related diagnostic model for psoriasis.
    Liu J; Wang Y; Sheng Y; Cai L; Wang Y
    PeerJ; 2024; 12():e17027. PubMed ID: 38436011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and prognostic significance of m6A-related genes in TP53-mutant non-small-cell lung cancer.
    Zhao Z; Wan J; Guo M; Wang Y; Yang Z; Zhou F; Li Z; Ming L
    J Clin Lab Anal; 2022 Jan; 36(1):e24118. PubMed ID: 34812534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression profiles and prognostic roles of m6A writers, erasers and readers in gastric cancer.
    Jing JJ; Zhao X; Li H; Sun LP; Yuan Y
    Future Oncol; 2021 Jul; 17(20):2605-2620. PubMed ID: 33878934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.
    Xu C; Liang T; Liu J; Fu Y
    Front Pharmacol; 2022; 13():931501. PubMed ID: 35910358
    [No Abstract]   [Full Text] [Related]  

  • 29. A novel signature constructed by cuproptosis-related RNA methylation regulators suggesting downregulation of YTHDC2 may induce cuproptosis resistance in colorectal cancer.
    Zhao Z; Miao Z; Hou Y; Zhong Y; Zhang X; Fang X
    Int Immunopharmacol; 2024 Sep; 139():112691. PubMed ID: 39029230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N6-Methyladenosine RNA Methylation Regulator-Related Alternative Splicing (AS) Gene Signature Predicts Non-Small Cell Lung Cancer Prognosis.
    Zhao Z; Cai Q; Zhang P; He B; Peng X; Tu G; Peng W; Wang L; Yu F; Wang X
    Front Mol Biosci; 2021; 8():657087. PubMed ID: 34179079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. m6A regulators are differently expressed and correlated with immune response of pancreatic adenocarcinoma.
    Zhang T; Sheng P; Jiang Y
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):2805-2822. PubMed ID: 35780396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental validation and comprehensive analysis of m6A methylation regulators in intervertebral disc degeneration subpopulation classification.
    Xu X; Shen L; Qu Y; Li D; Zhao X; Wei H; Yue S
    Sci Rep; 2024 Apr; 14(1):8417. PubMed ID: 38600232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression patterns and prognostic value of m
    Liu X; Liu L; Dong Z; Li J; Yu Y; Chen X; Ren F; Cui G; Sun R
    Am J Transl Res; 2019; 11(7):3972-3991. PubMed ID: 31396313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction and validation of stemness-related lncRNA pair signature for predicting prognosis in colorectal cancer.
    Thandar M; Zhu Y; Zhang X; Chen Z; Zhao Y; Huang S; Chi P
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11815-11828. PubMed ID: 37410143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of Genetic Alteration Signatures and Prognostic Values of m6A Regulatory Genes in Head and Neck Squamous Cell Carcinoma.
    Zhou X; Han J; Zhen X; Liu Y; Cui Z; Yue Z; Ding L; Xu S
    Front Oncol; 2020; 10():718. PubMed ID: 32547941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic, progressive and prognostic performance of m
    Zhuang Z; Chen L; Mao Y; Zheng Q; Li H; Huang Y; Hu Z; Jin Y
    Int J Biol Sci; 2020; 16(11):1785-1797. PubMed ID: 32398949
    [No Abstract]   [Full Text] [Related]  

  • 37. Prognostic and therapeutic implication of m6A methylation in Crohn disease.
    He Y; Hu Y; Yuan M; Xu W; Du Y; Liu J
    Medicine (Baltimore); 2022 Dec; 101(51):e32399. PubMed ID: 36595818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer.
    Zhang C; Zhang M; Ge S; Huang W; Lin X; Gao J; Gong J; Shen L
    Cancer Med; 2019 Aug; 8(10):4766-4781. PubMed ID: 31243897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction and validation of prognostic prediction established on N6-methyladenosine related genes in cervical squamous cell carcinoma.
    Chen D; Guo W; Yu H; Yang J
    Transl Cancer Res; 2022 Sep; 11(9):3064-3079. PubMed ID: 36237271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive Analysis of the Prognostic Role and Mutational Characteristics of m6A-Related Genes in Lung Squamous Cell Carcinoma.
    Gu C; Shi X; Qiu W; Huang Z; Yu Y; Shen F; Chen Y; Pan X
    Front Cell Dev Biol; 2021; 9():661792. PubMed ID: 33842487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.